Latest filing published 12 Apr 2023 for 国药现代, €8,700.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -33.8%Entry CN¥12.93 · Close at T+365 CN¥8.56
- +2.6%Entry CN¥9.80 · Close at T+365 CN¥10.05
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
李显林: trading record in brief
李显林 (senior executive) discloses dealings in 国药现代 to SSE / SZSE (CSRC). Between 7 December 2022 and 12 April 2023, the trades on record add up to 2 filings.
The open-market record is one-sided, with 2 purchases worth €10k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2023 alone, the filings show 1 purchase and no sales.
Most recently, on 12 April 2023, the filings show an open-market purchase worth €8,700 in 国药现代. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Companies and markets linked to 李显林
Open company profiles for insider transactions, fundamentals and analyst consensus when available.